Purification of myeloma cells is often performed by this method using anti-CD138 monoclonal antibodies conjugated to magnetic beads, since plasma cells, in contrast to other cells in the bone marrow, express high levels of the proteoglycan CD138 (syndecan-1) [7–9]. This evidence concerns the gene SDC1 and plasma cell myeloma.